TikTok creator Cate Elam posted about stopping semaglutide after 15 months, asking her 721.7K viewers to hold her accountable. While the video doesn't make specific medical claims, the decision to discontinue raises important questions about what happens when people stop GLP-1 medications.
What does this video actually claim?
The video shows Elam announcing her decision to stop semaglutide after 15 months of use. She doesn't make explicit claims about side effects or reasons for stopping, but asks for accountability from her audience regarding life after the medication.
The hashtags (#semaglutideweightloss, #lifeaftersemaglutide) suggest she's positioning this as educational content about the post-medication experience. This type of content has become increasingly common as more people share their GLP-1 journeys on social media.
What's missing is context about why she's stopping or what her healthcare provider recommended. The accountability request implies she expects challenges ahead.
What happens when people stop semaglutide?
The research is clear: most people regain weight when they stop semaglutide. The STEP 1 trial extension (Wilding et al., NEJM, 2022) found participants regained 11.6% of their body weight within a year of stopping the medication.
This isn't a failure of willpower. Semaglutide works by mimicking GLP-1, a hormone that regulates appetite and blood sugar. When you stop taking it, those hormonal effects disappear.
The STEP 4 trial specifically studied this discontinuation effect. Participants who switched from semaglutide to placebo regained two-thirds of their lost weight over 52 weeks, while those who continued the medication maintained their weight loss.
Is 15 months a typical treatment duration?
Fifteen months isn't unusually short for semaglutide use, but it's not the intended duration either. Clinical trials like STEP 1 ran for 68 weeks (about 16 months), but the medication is designed for long-term use.
Most clinical guidelines suggest semaglutide should be continued indefinitely for weight management, similar to medications for diabetes or high blood pressure. The FDA approval for Wegovy (the weight management formulation) doesn't specify a stopping point.
People stop for various reasons: cost (around $1,000-1,500 monthly without insurance), side effects, or personal preference. However, stopping typically means losing the metabolic benefits the medication provided.
What should viewers actually know?
Elam's experience will likely mirror what clinical trials show: gradual weight regain over 6-12 months. This isn't a personal failing but a predictable biological response to stopping a medication that affects hunger hormones.
The "accountability" framing, while well-intentioned, might inadvertently promote the idea that willpower alone can maintain semaglutide's effects. The evidence suggests otherwise.
If someone is considering stopping semaglutide, they should discuss strategies with their healthcare provider. Some doctors recommend lifestyle interventions, other medications, or planned breaks rather than abrupt discontinuation. The decision should be medical, not social media-driven.